o 9 of which are publicly-listed o 13 of which are privately-held · Of these, 15 new core portfolio companies were added during the period · 25/33 core portfolio companies pipeline products are in clinical stage programmes (2019: 14/18) · As of 31 December 2020, c.69% of NAV was invested in core portfolio companies, c. 25% was invested in non-core portfolio holdings, and c. 6% was held in cash. Roderick Wong, MD, Managing Partner and Chief Investment Officer of RTW Investments, LP (the Investment Manager ) commented: We are delighted to report strong results for the RTW Venture Fund during its first full year reporting period, despite the challenges of 2020 due to the COVID-19 pandemic. NAV returns of 54% during the calendar year and 88.5% since IPO in October 2019 reflect our successful full lifecycle crossover investing strategy in action.
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Quarterly Update
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Total Voting Rights
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Announcement of Share Issuance
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
About RTW Venture Fund Limited: RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients lives. RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further